RadNet Net Cash Flow 2010-2025 | RDNT

RadNet net cash flow from 2010 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
RadNet Annual Net Cash Flow
(Millions of US $)
2024 $397
2023 $215
2022 $-7
2021 $33
2020 $62
2019 $30
2018 $-41
2017 $31
2016 $20
2015 $0
2014 $-8
2013 $8
2012 $-2
2011 $2
2010 $-9
2009 $10
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.278B $1.830B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.637B 19.35
Encompass Health (EHC) United States $11.786B 24.99
DaVita (DVA) United States $11.101B 15.33
Chemed (CHE) United States $8.326B 26.17
Elanco Animal Health (ELAN) United States $6.367B 13.64
Option Care Health (OPCH) United States $5.217B 23.25
Amedisys (AMED) United States $3.132B 21.06
LifeStance Health (LFST) United States $2.275B 0.00
Addus HomeCare (ADUS) United States $2.034B 22.33
Astrana Health (ASTH) United States $1.600B 39.64
U.S Physical Therapy (USPH) United States $1.175B 30.33
Aveanna Healthcare Holdings (AVAH) United States $1.128B 64.22
Pennant (PNTG) United States $1.019B 37.40
Atai Life Sciences (ATAI) Germany $0.288B 0.00
Daxor (DXR) United States $0.035B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00